Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.

Abstract

A large proportion of failures on Category I therapy can be identified early. As three-quarters of patients with susceptibility results have MDR-TB, early referral for culture and drug susceptibility testing is critical for prompt initiation of appropriate therapy and improved outcomes.